News
23h
Medical Device Network on MSNDeepQure’s trial of RDN system for AF treatment approved in South Korea
The system is developed under the leadership of Seoul National University Hospital professor Chang-Wook Jeong.
B vitamins play a key role in managing homocysteine and supporting heart health. Based on this study, Vitamin B could be a ...
Topline data were announced from a phase 3 trial that evaluated baxdrostat in patients with uncontrolled or treatment resistant hypertension.
David’s blood pressure was dangerously high until he received specialized care and renal denervation at BIDMC’s Complex ...
SAN FRANCISCO -- The investigational selective glucocorticoid receptor modulator relacorilant led to improvements in blood pressure, fasting glucose, and weight for patients with adrenal ...
The BaxHTN study met its primary endpoint, and researchers will present more data at the ESC Congress later this summer.
In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...
At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients ...
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical trial involving patients with uncontrolled or treatment-resistant hypertension. In the trial, patients who ...
Other standout performers included cycling, which had stronger effects than walking in both pressure types. Walking, though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results